People Innovation Excellence

Biweekly meeting with GECCO

On Tuesday, 26 May 2020, Jakarta was still under limited social interaction law, which makes us have to work from our home. Even though the COVID-19 has limited our outdoor activities, we are still be able to conduct our research collaboration with our international partners. On this day, we had our biweekly meeting with other GECCO teams, discussing the smoking-related impact on colorectal cancer. Smoking-related is one study area that we have been studied for some time with our partner BioRealm. In the meeting, we shared what we have found in our previous study and also mentioned the SmokeScreen panel, a genotyping array that BioRealm is developing. We also proposed a bioinformatics pipeline system for GECCO team to use. Initially, this pipeline was aimed for our height – CRC research project with IARC, however, the bioinformatics pipeline can also be used by other teams in GECCO as well.


Published at : Updated

Periksa Browser Anda

Check Your Browser

Situs ini tidak lagi mendukung penggunaan browser dengan teknologi tertinggal.

Apabila Anda melihat pesan ini, berarti Anda masih menggunakan browser Internet Explorer seri 8 / 7 / 6 / ...

Sebagai informasi, browser yang anda gunakan ini tidaklah aman dan tidak dapat menampilkan teknologi CSS terakhir yang dapat membuat sebuah situs tampil lebih baik. Bahkan Microsoft sebagai pembuatnya, telah merekomendasikan agar menggunakan browser yang lebih modern.

Untuk tampilan yang lebih baik, gunakan salah satu browser berikut. Download dan Install, seluruhnya gratis untuk digunakan.

We're Moving Forward.

This Site Is No Longer Supporting Out-of Date Browser.

If you are viewing this message, it means that you are currently using Internet Explorer 8 / 7 / 6 / below to access this site. FYI, it is unsafe and unable to render the latest CSS improvements. Even Microsoft, its creator, wants you to install more modern browser.

Best viewed with one of these browser instead. It is totally free.

  1. Google Chrome
  2. Mozilla Firefox
  3. Opera
  4. Internet Explorer 9